Sdiptech (Q3 review): Sales beat, Base Case raised to SEK315 - Redeye
Bildkälla: Stockfoto

Sdiptech (Q3 review): Sales beat, Base Case raised to SEK315 - Redeye

Redeye updates its estimates and valuation after Sdiptech's Q3 2026 report. Net sales beat our estimate by 7%, driven by 13% organic growth in the core business, while adj. EBITA came in 2% above our forecast. As in Q2, the beat narrowed on the way down the P&L: gross margin fell to 58.1%, against our 61.4%. Overall, we view Q3 as another solid step: organic growth is now broad-based across all four business areas, two more UK acquisitions were closed and the bond refinancing lowers the cost of debt. We raise our Base Case to SEK315 (300).

Redeye updates its estimates and valuation after Sdiptech's Q3 2026 report. Net sales beat our estimate by 7%, driven by 13% organic growth in the core business, while adj. EBITA came in 2% above our forecast. As in Q2, the beat narrowed on the way down the P&L: gross margin fell to 58.1%, against our 61.4%. Overall, we view Q3 as another solid step: organic growth is now broad-based across all four business areas, two more UK acquisitions were closed and the bond refinancing lowers the cost of debt. We raise our Base Case to SEK315 (300).
Börsvärldens nyhetsbrev